HomePHXM • EPA
add
Phaxiam Therapeutics SA
Previous close
€2.92
Day range
€2.87 - €2.96
Year range
€2.60 - €11.70
Market cap
17.21M EUR
Avg Volume
4.59K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 851.00K | -83.71% |
Operating expense | 2.54M | 200.12% |
Net income | -5.60M | -194.30% |
Net profit margin | -657.70 | -678.91% |
Earnings per share | — | — |
EBITDA | -1.64M | -133.36% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.47M | -73.00% |
Total assets | 51.31M | 12.00% |
Total liabilities | 25.70M | 15.10% |
Total equity | 25.61M | — |
Shares outstanding | 6.07M | — |
Price to book | 0.69 | — |
Return on assets | — | — |
Return on capital | -9.33% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.60M | -194.30% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2004
Website
Employees
51